Researchers at the International Centre for Genetic Engineering and Biotechnology in New Delhi said they are making strides with a vaccine for the dengue virus, which is being developed using hepatitis B vaccine technology. Preclinical tests showed the vaccine addressed all four dengue virus strains, researchers said. They estimate being able to test the vaccine in human trials in around five years.

Related Summaries